Tresmares Capital has taken a minority stake in Rioja Nature Pharma
Madrid – CFI is pleased to announce that it acted as exclusive financial advisor to Rioja Nature Pharma in its sale of a minority stake to Tresmares Capital through a sharecapital increase.
Rioja Nature Pharma is a leading dietary supplements manufacturer for third parties with expected revenues of >€40M in 2023.
Tresmares Capital is a pan-European growth-focused alternative investment firm operating in Spain, the United Kingdom and Portugal. Founded in 2020 and comprising a team of 50 investment professionals, the firm offers an extensive range of financing solutions to both high-growth SMEs and their private equity backers.
This transaction closed in November 2023.
Food & Beverage & Agribusiness
has sold minority stake to
Transaction details
Leading dietary supplement provider Rioja Nature Pharma has sold a minority stake to private equity fund Tresmares Capital
This transaction was advised by:
Our latest transactions
Software & IT Services
has been sold to
a portfolio company of
Transaction details
LetsBuild Aproplan, a digital construction management platform used by thousands of companies to streamline on-site workflows has been sold to Causeway Technologies, a company that provides enterprise and cloud software to over 3,000 customers worldwide
Food & Beverage & Agribusiness
has sold a majority share to
Transaction details
AgroquÃmica Codiagro, a distinguished Spanish provider of biostimulants, has sold a majority share to Sustainable Agro Solutions (SAS Group), backed by Stirling Square Capital Partners
